AHL
Asset Logo

Adrad Holdings Limited

🇦🇺 ASX

🚗 AUTOMOBILES

Compare
Add to watchlist
👑 Overview

📈 Performance

💰 Dividends

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-23.83%
Annual Growth

2 years average annual growth

💰

3.72%
Annual dividend yield

Based on the most recent dividend

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

3
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Adrad Holdings Ltd. manufactures and supplies radiators for motor vehicles. The firm designs and manufactures heat transfer solutions for OE customers globally and the manufacture, importation and distribution of automotive parts for the aftermarket. The firm operates through two segments: Heat Transfer Solutions and Adrad Distribution. The Heat Transfer Solutions segment designs and manufactures industrial cooling solutions for use in road transport and heavy vehicles, mining, power generation, data centers and rail industries. Adrad Distribution segment imports and distributes radiators, mobile and stationary heat exchange products and a variety of automotive parts for the Australian and New Zealand automotive and industrial markets. The firm has facilities across Australia, New Zealand and Thailand, a number of which include warehousing, manufacturing and service facilities.

📈 Performance

Price History

-58.33%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💰 Dividends

Payouts

💰 Annual Dividend Yield*

3.72%

💰 Annual Dividend Earnings Per $1,000 invested**

$37.22

💰 Most Recent Dividend Franked Percentage Estimate

100.00%

💰 Average Dividend Franked Percentage Estimate

100.00 %

💰 Dividend reinvestment

Learn more

* Based on the most recent dividend

** Calculated by multiplying the most recent dividend yield by $1,000

Estimate your dividend

If you held

$

of AHL, your last dividend payment(s) would have been:

$ 287.5

on Thu Oct 03 2024

$ 201.06

on Wed Apr 03 2024

*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.

Dividend History

1Y

5Y

10Y

Graph

Table

Year
Yearly Dividend Earnings Per Share
Franking Estimate

2025

$0.00

0.00%

2024

$0.03

100.00%

2023

$0.02

50.00%

2022

$0.00

0.00%

2021

$0.00

0.00%

2020

$0.00

0.00%

2019

$0.00

0.00%

2018

$0.00

0.00%

2017

$0.00

0.00%

2016

$0.00

0.00%

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.63

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in AHL

3

📊 Total Capital Earnings

$2K

🔃 Average investment frequency

22 weeks

💵 Average investment amount

$923

Last time a customer invested in AHL

104 days
AHL investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

33%

Less than 50k

50%
👶 Age of investors

18 - 25

26 - 34

33%

35 - 90

67%
🙋 Legal gender of investors

Female

33%

Male

67%

Pearlers who invest in AHL also invest in...

Clinuvel Pharmaceuticals Limited

CUV

Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-02-13. The firm is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company’s pharmaceuticals product development includes PRENUMBRA and NEURACTHEL. Its PhotoCosmetics product development includes CYACELLE and DNA Repair Assist and Melanogenesis. PRENUMBRA is a formulation of afamelanotide designed to provide a flexible dose in identified patient groups. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH).

🙌 Performance (5Yr p.a)

-4.56%

📊 Share price

$11.85 AUD

🧬 BIOTECHNOLOGY

Find Out More

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

🙌 Performance (5Yr p.a)

16.92%

📊 Share price

$137.98 AUD

🌏 GLOBAL

⛳️ DIVERSIFIED

🤖 TECHNOLOGY

📈 HIGH PRICE GROWTH

Antipa Minerals Ltd. engages in the exploration and development of mineral properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2011-04-20. Its tenement holding covers over 5,100 square kilometers (km2) situated within an underexplored gold-copper-silver-cobalt province. The 100%-owned Minyari Dome Project area covers over 900 km2 and hosts the Minyari and WACA gold-copper-silver-cobalt deposits. The company has three growth projects covering a total of 4,200 km2, including Citadel Project, Wilki Project and Paterson Project. The Wilki Project comprises approximately 1,470km2 in total landholding and is located on the southern portion of its tenement ground in the Paterson Province of Western Australia. The Paterson Project comes to within 22 km of Newmont’s Telfer gold-copper mine and 8km of Rio Tinto’s Winu copper-gold-silver development project. The 1,200 km2 Citadel JV Project adjoins its Paterson Project and includes the Magnum Dome, an area of approximately 30km2.

🙌 Performance (5Yr p.a)

448.75%

📊 Share price

$0.38 AUD

⛏️ MINING

Catapult Group International Ltd. engages in the development and supply of wearable athlete tracking and analytics solutions. The company is headquartered in Prahan, Victoria. The company went IPO on 2014-12-19. The Company’s products are designed to optimize performance, avoid injury, and improve return to play. The firm operates through three segments: Performance & Health, Tactics & Coaching and Media & Other. The Performance & Health segment is engaged in the design, development and supply of wearable technology and athlete monitoring software solutions to sports teams, athletes, and the prosumer market. The Tactics & Coaching segment is engaged in the design, development and supply of video analysis, editing, and publishing software solutions to sports teams. The Media & Other segment provides media licensing, athlete management and professional services to customers. Its wearable and video solutions are provided to elite clients on both a subscription and upfront capital sales basis. The firm works with more than 3,800 elite teams in over 40 sports.

🙌 Performance (5Yr p.a)

51.45%

📊 Share price

$3.93 AUD

🤖 TECHNOLOGY

Corporate Travel Management Ltd. engages in managing the procurement and delivery of travel and accommodation agency services for its clients. The company is headquartered in Brisbane, Queensland and currently employs 3,192 full-time employees. The company went IPO on 2010-12-15. The principal activities of the Company, consists of managing the procurement and delivery of travel and accommodation agency services for its clients. The Company’s segments include Australia and New Zealand, North America, Asia, and Europe. Its services include global corporate travel, and global meetings and events management. The firm designs global travel programs that design services and solutions for global business travel. The firm's technology framework enables it to integrate a range of tools into one travel portal, providing its global customers with a single, customized and configurable platform that meets the needs of user for maximum adoption, compliance and user-experience. The firm's specialist meetings and events division, Event Travel Management (ETM), consolidates its meetings and events expenditure.

🙌 Performance (5Yr p.a)

12.55%

📊 Share price

$15.04 AUD

📈 HIGH PRICE GROWTH

🏨 HOTELS, RESTAURANTS & LEISURE

Want more shares? Try these...

AHLNB

AHKDB

📊 Share price

$0.03 AUD
Compare
Add to watchlist